Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
Titel:
Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
Auteur:
Buren, George Van Ramanathan, Ramesh K. Krasinskas, Alyssa M. Smith, Ryan P. Abood, Gerard J. Bahary, Nathan Lembersky, Barry C. Shuai, Yongli Potter, Douglas M. Bartlett, David L Zureikat, Amer H. Zeh, Herbert J. James Moser, A.